-+ 0.00%
-+ 0.00%
-+ 0.00%

CRINETICS PHARMACEUTICALS TO PROVIDE PALSONIFY BUSINESS UPDATE AND ANNOUNCE TOPLINE RESULTS FROM FOURTH COHORT OF PHASE 2 TRIAL OF ATUMELNANT IN CONGENITAL ADRENAL HYPERPLASIA

Reuters·01/04/2026 21:00:00

Please log in to view news